References

An essay on the shaking palsy. 1817

10.1176/jnp.14.2.223 · 2002 · External reference

Autonomic dysfunction in Parkinson's disease

10.1007/s100720300035 · 2003 · External reference

10.1007/s00702-009-0240-y

10.1007/s00702-009-0240-y · External reference

10.1016/s0161-813x(02)00099-2

10.1016/s0161-813x(02)00099-2 · External reference

10.1093/hmg/ddp012

10.1093/hmg/ddp012 · External reference

10.1016/s0166-4328(01)00309-6

10.1016/s0166-4328(01)00309-6 · External reference

The soluble isoform of CX3CL1 is necessary for neuroprotection in a mouse model of Parkinson's disease

10.1523/jneurosci.0539-12.2012 · 2012 · External reference

The synucleins

2002 · External reference

Alpha-synuclein and Parkinson's disease

10.1096/fj.03-0338rev · 2004 · External reference

Mutation in the alpha-synuclein gene identified in families with Parkinson's disease

10.1126/science.276.5321.2045 · 1997 · External reference

10.1111/j.1582-4934.2010.01010.x

10.1111/j.1582-4934.2010.01010.x · External reference

10.1016/s0002-9440(10)64553-1

10.1016/s0002-9440(10)64553-1 · External reference

Molecular pathogenesis of Parkinson disease: insights from genetic studies

10.1017/s1462399409001148 · 2009 · External reference

10.1038/nrg1831

10.1038/nrg1831 · External reference

10.1038/ncpneuro0126

10.1038/ncpneuro0126 · External reference

10.1146/annurev-pathol-011110-130242

10.1146/annurev-pathol-011110-130242 · External reference

Genes, proteins, and neurotoxins involved in Parkinson's disease

10.1016/j.pneurobio.2004.05.002 · 2004 · External reference

Immunohistochemical analyses of fibroblast growth factor receptor-1 in the human substantia nigra. Comparison between normal and Parkinson's disease cases

10.1016/s0006-8993(98)00132-2 · 1998 · External reference

Embryonic stem cell-derived L1 overexpressing neural aggregates enhance recovery in Parkinsonian mice

10.1093/brain/awp290 · 2010 · External reference

10.1073/pnas.0710685105

10.1073/pnas.0710685105 · External reference

CX3CL1 reduces neurotoxicity and microglial activation in a rat model of Parkinson's disease

10.1186/1742-2094-8-9 · 2011 · External reference

10.1007/s10048-011-0294-5

10.1007/s10048-011-0294-5 · External reference

10.1016/j.bbadis.2009.12.009

10.1016/j.bbadis.2009.12.009 · External reference

10.1097/nen.0b013e3181567f17

10.1097/nen.0b013e3181567f17 · External reference

Axon pathology in Parkinson's disease and Lewy body dementia hippocampus contains alpha-, beta-, and gamma-synuclein

10.1073/pnas.96.23.13450 · 1999 · External reference

10.1002/ana.10324

10.1002/ana.10324 · External reference

10.1002/mds.23376

10.1002/mds.23376 · External reference

10.1161/circresaha.111.247916

10.1161/circresaha.111.247916 · External reference

Convergence of miRNA expression profiling, α-synuclein interacton and GWAS in Parkinson's disease

10.1371/journal.pone.0025443 · 2011 · External reference

10.1002/mds.23714

10.1002/mds.23714 · External reference

Levodopa-induced dyskinesia in Parkinson's disease: clinical features, pathogenesis, prevention and treatment

10.1136/pgmj.2006.054759 · 2007 · External reference

Deep-Brain Stimulation for Parkinson's Disease

10.1056/nejmct1208070 · 2012 · External reference

10.1007/s10048-007-0116-y

10.1007/s10048-007-0116-y · External reference

Transcriptional analysis of multiple brain regions in Parkinson's disease supports the involvement of specific protein processing, energy metabolism, and signaling pathways, and suggests novel disease mechanisms

10.1002/ajmg.b.30195 · 2005 · External reference

Translational proteomics in neurodegenerative diseases – 16th HUPO BPP Workshop September 5, 2011, Geneva, Switzerland

10.1002/pmic.201290017 · 2012 · External reference

Bioconductor: open software development for computational biology and bioinformatics

10.1186/gb-2004-5-10-r80 · 2004 · External reference

arrayQualityMetrics–a bioconductor package for quality assessment of microarray data

2009 · External reference

Exploration, normalization, and summaries of high density oligonucleotide array probe level data

10.1093/biostatistics/4.2.249 · 2003 · External reference

Linear models and empirical bayes methods for assessing differential expression in microarray experiments

10.2202/1544-6115.1027 · 2004 · External reference

Pathway studio–the analysis and navigation of molecular networks

2003 · External reference

10.1093/acprof:oso/9780199591756.001.0001

10.1093/acprof:oso/9780199591756.001.0001 · 2011 · External reference

Pajek – Program for Large Network Analysis

1998 · External reference

Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources

10.1038/nprot.2008.211 · 2009 · External reference

Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists

10.1093/nar/gkn923 · 2009 · External reference

DAVID: Database for Annotation, Visualization, and Integrated Discovery

10.1186/gb-2003-4-5-p3 · 2003 · External reference

KEGG: kyoto encyclopedia of genes and genomes

10.1093/nar/28.1.27 · 2000 · External reference

10.1016/j.nbd.2005.06.004

10.1016/j.nbd.2005.06.004 · External reference

Novel 9q34.11 gene deletions encompassing combinations of four Mendelian disease genes: STXBP1, SPTAN1, ENG, and TOR1A

10.1038/gim.2012.65 · 2012 · External reference

10.1016/j.pneurobio.2010.04.006

10.1016/j.pneurobio.2010.04.006 · External reference

UNC13A is a modifier of survival in amyotrophic lateral sclerosis

10.1016/j.neurobiolaging.2011.10.029 · 2012 · External reference

10.1016/j.expneurol.2004.08.021

10.1016/j.expneurol.2004.08.021 · External reference

10.1002/dneu.20916

10.1002/dneu.20916 · External reference

10.1016/s0197-0186(03)00080-9

10.1016/s0197-0186(03)00080-9 · External reference

10.1016/j.neuint.2010.05.012

10.1016/j.neuint.2010.05.012 · External reference

A Wnt1 regulated Frizzled-1/β-Catenin signaling pathway as a candidate regulatory circuit controlling mesencephalic dopaminergic neuron-astrocyte crosstalk: Therapeutical relevance for neuron survival and neuroprotection

10.1186/1750-1326-6-49 · 2011 · External reference

10.1007/s11060-009-0035-x

10.1007/s11060-009-0035-x · External reference

10.1002/cne.21161

10.1002/cne.21161 · External reference

10.1242/dev.125.17.3417

10.1242/dev.125.17.3417 · External reference

BMP and FGF regulate the development of EGF-responsive neural progenitor cells

10.1242/dev.127.22.4993 · 2000 · External reference

From the Cover: Epidermal growth factor receptor is a preferred target for treating Amyloid-induced memory loss

10.1073/pnas.1208011109 · 2012 · External reference

10.1007/s12035-008-8032-1

10.1007/s12035-008-8032-1 · External reference

Leptin as a neuroprotective agent

10.1016/j.bbrc.2008.01.063 · 2008 · External reference

Synucleinopathies: clinical and pathological implications

10.1001/archneur.58.2.186 · 2001 · External reference

10.1146/annurev-neuro-061010-113613

10.1146/annurev-neuro-061010-113613 · External reference

10.1111/j.1749-6632.2000.tb06900.x

10.1111/j.1749-6632.2000.tb06900.x · External reference

α-Synuclein in Parkinson's disease

10.1101/cshperspect.a009399 · 2012 · External reference

Tau and Parkinson Disease

10.1001/jama.286.18.2324 · 2001 · External reference

10.1093/hmg/ddl190

10.1093/hmg/ddl190 · External reference

10.1016/j.biocel.2010.07.016

10.1016/j.biocel.2010.07.016 · External reference

Tau therapeutic strategies for the treatment of Alzheimer's disease

10.2174/156802606776743057 · 2006 · External reference

10.1002/ana.20819

10.1002/ana.20819 · External reference

10.1016/j.febslet.2006.04.064

10.1016/j.febslet.2006.04.064 · External reference

Accumulation of tumor-suppressor PTEN in Alzheimer neurofibrillary tangles

10.1016/j.neulet.2009.12.078 · 2010 · External reference

Tumor suppressor PTEN affects tau phosphorylation: deficiency in the phosphatase activity of PTEN increases aggregation of an FTDP-17 mutant Tau

10.1186/1750-1326-1-7 · 2006 · External reference

10.1038/ng882

10.1038/ng882 · External reference

10.1080/02656730500041871

10.1080/02656730500041871 · External reference

Disease-specific, neurosphere-derived cells as models for brain disorders

10.1242/dmm.005447 · 2010 · External reference

10.1111/j.1471-4159.2011.07284.x

10.1111/j.1471-4159.2011.07284.x · External reference

10.1016/j.semcdb.2011.08.005

10.1016/j.semcdb.2011.08.005 · External reference

10.1006/bbrc.2000.4253

10.1006/bbrc.2000.4253 · External reference

10.1111/j.1460-9568.2004.03254.x

10.1111/j.1460-9568.2004.03254.x · External reference

Fractalkine modulates TNF-alpha secretion and neurotoxicity induced by microglial activation

10.1002/(sici)1098-1136(20000215)29:4<305::aid-glia2>3.0.co;2-v · 2000 · External reference

Glutamate receptors as therapeutic targets for Parkinson's disease

10.2174/187152709789824606 · 2009 · External reference

10.1212/wnl.0b013e31824c4728

10.1212/wnl.0b013e31824c4728 · External reference

10.1523/jneurosci.0702-05.2006

10.1523/jneurosci.0702-05.2006 · External reference

Axon responses of embryonic stem cell-derived dopaminergic neurons to semaphorins 3A and 3C

10.1002/jnr.22268 · 2010 · External reference

Calpain as a potential therapeutic target in Parkinson's disease

10.2174/187152708784936680 · 2008 · External reference

Circulating interleukin-10 and interleukin-12 in Parkinson's disease

10.1111/j.1600-0404.2008.01103.x · 2009 · External reference

Interleukin-6 levels in cerebrospinal fluid inversely correlate to severity of Parkinson's disease

10.1111/j.1600-0404.1998.tb01736.x · 1998 · External reference

10.1261/rna.783108

10.1261/rna.783108 · External reference

Parkinson's disease is associated with hippocampal atrophy

10.1002/mds.10444 · 2003 · External reference

10.1016/j.jchemneu.2011.01.005

10.1016/j.jchemneu.2011.01.005 · External reference

10.1016/j.nbd.2011.12.046

10.1016/j.nbd.2011.12.046 · External reference

10.1093/hmg/ddr210

10.1093/hmg/ddr210 · External reference

Gene expression profiling of substantia nigra dopamine neurons: further insights into Parkinson's disease pathology

10.1093/brain/awn323 · 2009 · External reference

Micro-RNA speciation in fetal, adult and Alzheimer's disease hippocampus

10.1097/wnr.0b013e3280148e8b · 2007 · External reference

10.1083/jcb.150.3.589

10.1083/jcb.150.3.589 · External reference